Allen & Overy advises Keensight Capital and Valiantys on the financing of the acquisition of Expium
For media enquiries relating to this topic, please contact:
Headlines in this article
Related news and insights
News: 30 November 2023
News: 20 October 2023
News: 04 October 2023
News: 15 February 2023
This acquisition allows Valiantys to expand its presence in the US market and, through the complementary expertise of Expium, to strengthen its offering.
The transaction involved the Paris office of Allen & Overy, with a team composed of partner Géraldine Lezmi and associate Constance Frayssineau.